Trial to Evaluate the Efficacy of the HLPFC Coil Deep Transcranial Magnetic Stimulation System in Treating Attention Deficit and Hyperactivity Disorder (ADHD) in Adults

Attention Deficit Disorder Patients Clinical Trial

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT01737476
• Other study ID #: sor010912ctil
• Status: Not yet recruiting
• Phase: N/A
• First received: September 20, 2012
• Last updated: November 26, 2012
• Start date: November 2012

Study information

• Verified date: November 2012
• Source: Soroka University Medical Center
• Contact: Hadar Shalev, MD
• Phone: 97286400353
• Email: shalev[@]bgu.ac.il
• Is FDA regulated: No
• Health authority: Israel: Ethics Commission
• Study type: Interventional

Clinical Trial Summary

The aim of the study is to investigate the efficacy of trans-cranial magnetic stimulation in treating attention deficit disorder in adults.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. primary completion date: August 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• 18-65 years

• ADD/ADHD

Exclusion Criteria:

• any DSM-IV psychiatric disorder except ADD/ADHD

• use of psychoactive medications

• Epilepsy

• brain injury

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Attention Deficit Disorder Patients
• Attention Deficit Disorder with Hyperactivity

Intervention

Procedure:
• Transcranial Magnetic Stimulation. PFC

Locations

Country	Name	City	State
Israel	Ben-Gurion University	Beer-Sheva

Sponsors (1)

Lead Sponsor	Collaborator
Soroka University Medical Center

Country where clinical trial is conducted

Israel,